Closing Figures Unveiled: RxSight Inc (RXST) Drop -3.52, Closes at $8.49

Kiel Thompson

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

RxSight Inc (NASDAQ: RXST) closed the day trading at $8.49 down -3.52% from the previous closing price of $8.8. In other words, the price has decreased by -$3.52 from its previous closing price. On the day, 0.75 million shares were traded. RXST stock price reached its highest trading level at $8.96 during the session, while it also had its lowest trading level at $8.47.

Ratios:

For a better understanding of RXST, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.70 and its Current Ratio is at 13.93. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.

On July 10, 2025, Jefferies Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $9.

Wells Fargo Downgraded its Overweight to Equal Weight on July 09, 2025, while the target price for the stock was maintained at $9.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 12 ’25 when Fountain Tamara sold 7,000 shares for $25.71 per share. The transaction valued at 180,002 led to the insider holds 24,793 shares of the business.

TAMARA R FOUNTAIN bought 7,000 shares of RXST for $180,002 on Mar 12 ’25. On Jan 22 ’25, another insider, Maniar Shweta, who serves as the Director of the company, sold 3,519 shares for $30.87 each. As a result, the insider received 108,618 and left with 7,383 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXST now has a Market Capitalization of 347376512 and an Enterprise Value of 131600528. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.36 while its Price-to-Book (P/B) ratio in mrq is 1.25. Its current Enterprise Value per Revenue stands at 0.895 whereas that against EBITDA is -3.347.

Stock Price History:

The Beta on a monthly basis for RXST is 1.16, which has changed by -0.8276142 over the last 52 weeks, in comparison to a change of 0.1719923 over the same period for the S&P500. Over the past 52 weeks, RXST has reached a high of $55.57, while it has fallen to a 52-week low of $6.32. The 50-Day Moving Average of the stock is -1.73%, while the 200-Day Moving Average is calculated to be -53.67%.

Shares Statistics:

Over the past 3-months, RXST traded about 1.41M shares per day on average, while over the past 10 days, RXST traded about 822130 shares per day. A total of 40.91M shares are outstanding, with a floating share count of 37.46M. Insiders hold about 8.45% of the company’s shares, while institutions hold 94.05% stake in the company. Shares short for RXST as of 1757894400 were 4780783 with a Short Ratio of 3.40, compared to 1755216000 on 5774428. Therefore, it implies a Short% of Shares Outstanding of 4780783 and a Short% of Float of 12.2700006.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.